Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 16, keine Gesamtzahl für „study“
Suchtreffer
Begriffe & Kennungen
Bortezomib Accord · 4.8 · Mantle cell lymphoma In study LYM-3002 in which bortezomib was administered with rituximab, cyclophosphamide,
Eintrag öffnenBortezomib Accord · 4.8 · Mantle cell lymphoma In study LYM-3002 in which bortezomib was administered with rituximab, cyclophosphamide,
Eintrag öffnenBortezomib Accord · 4.8 · Table 10: Incidence of peripheral neuropathy in study LYM-3002 by toxicity and treatment discontinuation due t
Eintrag öffnenBortezomib Accord · 4.8 · Table 10: Incidence of peripheral neuropathy in study LYM-3002 by toxicity and treatment discontinuation due t
Eintrag öffnenBortezomib Accord · 4.8 · Table 8 Adverse reactions in patients with mantle cell lymphoma treated with BzR-CAP in a clinical study Syste
Eintrag öffnenBortezomib Accord · 4.8 · Table 8 Adverse reactions in patients with mantle cell lymphoma treated with BzR-CAP in a clinical study Syste
Eintrag öffnenBortezomib Fresenius Kabi · 4.5 · A drug-drug interaction study assessing the effect of melphalan-prednisone on the pharmacokinetics of bortezom
Eintrag öffnenBortezomib Fresenius Kabi · 4.5 · A drug-drug interaction study assessing the effect of melphalan-prednisone on the pharmacokinetics of bortezom
Eintrag öffnenBortezomib Fresenius Kabi · 4.5 · A drug-drug interaction study assessing the effect of rifampicin, a potent CYP3A4 inducer, on the pharmacokine
Eintrag öffnenBortezomib Fresenius Kabi · 4.5 · A drug-drug interaction study assessing the effect of rifampicin, a potent CYP3A4 inducer, on the pharmacokine
Eintrag öffnenBortezomib Fresenius Kabi · 4.5 · In a drug-drug interaction study assessing the effect of omeprazole, a potent CYP2C19 inhibitor, on the pharma
Eintrag öffnenBortezomib Fresenius Kabi · 4.5 · In a drug-drug interaction study assessing the effect of omeprazole, a potent CYP2C19 inhibitor, on the pharma
Eintrag öffnenBortezomib Fresenius Kabi · 4.5 · In the same drug-drug interaction study assessing the effect of dexamethasone, a weaker CYP3A4 inducer, on the
Eintrag öffnenBortezomib Fresenius Kabi · 4.5 · In the same drug-drug interaction study assessing the effect of dexamethasone, a weaker CYP3A4 inducer, on the
Eintrag öffnenBortezomib Fresenius Kabi · 4.8 · 22 Table 10: Incidence of peripheral neuropathy in study LYM-3002 by toxicity and treatment discontinuation du
Eintrag öffnenBortezomib Fresenius Kabi · 4.8 · Mantle cell lymphoma In study LYM-3002 in which bortezomib was administered with rituximab, cyclophosphamide,
Eintrag öffnenBortezomib Fresenius Kabi · 4.8 · Mantle cell lymphoma In study LYM-3002 in which bortezomib was administered with rituximab, cyclophosphamide,
Eintrag öffnenBortezomib Fresenius Kabi · 4.8 · Retreatment of patients with relapsed multiple myeloma In a study in which bortezomib retreatment was administ
Eintrag öffnenBortezomib Fresenius Kabi · 4.8 · Retreatment of patients with relapsed multiple myeloma In a study in which bortezomib retreatment was administ
Eintrag öffnenBortezomib Fresenius Kabi · 4.8 · Table 10: Incidence of peripheral neuropathy in study LYM-3002 by toxicity and treatment discontinuation due t
Eintrag öffnen